Shortage reports
Actual shortage:
283 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
2953 (91%)
3247
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
410 (94%)
Reversed:
23 (5%)
435
483 (13%)
16 (6%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-16 | 2021-09-30 | 120473 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-04-27 | 2023-06-09 | 190728 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-04-29 | 2021-05-13 | 138294 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-06-07 | 2025-04-28 | 229945 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2022-02-17 | 2022-03-24 | 155152 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2021-03-25 | 2021-04-01 | 136314 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2024-04-25 | 2025-03-13 | 226174 |
| TEVA-BUSPIRONE | 10MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86846 |
| TEVA-BUSPIRONE | 10MG | TABLET | Actual shortage | 2025-11-20 | 2026-01-15 | 272295 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-01-19 | 2023-04-28 | 181605 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2023-06-08 | 2023-10-19 | 194154 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-06-16 | 2023-07-28 | 195115 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2020-02-07 | 2020-06-11 | 105583 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-08-22 | 2019-11-01 | 92192 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-01-19 | 2023-06-09 | 181599 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2019-06-27 | 2019-11-01 | 87690 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2022-09-30 | 2022-12-22 | 170792 |
| TEVA-CANDESARTAN | 32MG | TABLET | Actual shortage | 2026-01-08 | 2026-01-09 | 275527 |
| TEVA-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183413 |
| TEVA-CANDESARTAN | 32MG | TABLET | Resolved | 2020-07-16 | 2020-08-21 | 120476 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Discontinued | 2020-05-14 | 2020-05-14 | 115085 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104263 |
| TEVA-ARIPIPRAZOLE | 5MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104283 |
| TEVA-ATENOLOL | 50MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106142 |
| TEVA-ATENOLOL | 100MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106145 |
| TEVA-ATENOLOL/CHLORTHALIDONE | 25MG 100MG | TABLET | Discontinued | 2020-01-21 | 2020-01-21 | 103781 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64609 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| TEVA-ATORVASTATIN | 80MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258655 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258613 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258541 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
| TEVA-BETAHISTINE | 16MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266371 |
| TEVA-BETAHISTINE | 8MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266368 |
| TEVA-BETAHISTINE | 24MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266374 |
| TEVA-CANDESARTAN | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258724 |